Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma.
03/03/2020
/
Publications
/
Survival
A study by the Samsung group from Korea published in the Green Journal. A total of 103 patients treated with proton therapy including 70 in the PS group and 33...
Proton Beam Therapy Is a Safe and Effective Treatment in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESCC).
05/06/2020
/
Publications
/
Toxicity
Survival
This study from Japan reported results of 54 esophageal cancer patients who are over 75 years old treated with PBT. 38 inoperable patients (70.4%) and 16...
Incidence and Onset of Severe Cardiac Events After Radiotherapy for Esophageal Cancer.
26/06/2020
/
Publications
/
Survival
The relatively higher cardiac dose exposure for esophageal cancer (EC) may result in the earlier onset of cardiac diseases. This MD Anderson study analyzed 479...
Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma.
28/04/2020
/
Publications
/
Hypofractionation
Survival
Toxicity
Published by the NCC group in Korea, this study reported outcomes of 45 patients including 37 had recurrent and/or residual disease treated with PBT to a total...
Proton therapy following induction chemotherapy for pediatric and adolescent nasopharyngeal carcinoma.
07/09/2019
/
Publications
/
Chemotherapy
Survival
A study by the Jacksonville group. Seventeen patients with nonmetastatic nasopharyngeal carcinoma underwent double-scattered proton therapy. With the median...
PBT outcomes for localized unresectable hepatocellular carcinoma.
03/01/2019
/
Publications
/
Survival
Toxicity
A MD Anderson study published in the Green Journal reported outcomes of forty-six patients with HCC, Child-Pugh class of A or B, no prior radiotherapy treated...
Comparison of Grade 4 Lymphopenia With PT Vs Photon Therapy for Esophageal Cancer.
01/01/2019
/
Publications
/
Survival
Grade 4 lymphopenia (G4L) during radiation therapy (RT) is associated with higher rates of distant metastasis and decreased overall survival. 79 patients...
Role of dose escalation and PT in perioperative or definitive treatment of chondrosarcoma and chordoma
01/01/2019
/
Publications
/
Survival
This study analyzed a total of 863 patients with chondrosarcoma and 715 patients with chordoma treated with proton or conventional radiation therapy. This study...
Effectiveness of Particle Radiotherapy in Various Stages of HCC
11/03/2018
/
Publications
/
Survival
A retrospective report from Japan. Eighty-three patients with HCC underwent particle therapy including proton beam radiation in 58 patients and carbon ion...
Treatment outcomes of proton or carbon ion therapy for skull base chordoma
11/11/2018
/
Publications
/
Survival
An outcome report by the Hyogo Ion Beam Medical Center in Japan. Twenty-four patients including eleven (46%) received PT and 13 (54%) received CIT reported the...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.